Beta Bionics, Inc. BBNX
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 30.28% | 37.76% | 56.62% | 57.15% | 63.14% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 30.28% | 37.76% | 56.62% | 57.15% | 63.14% |
| Cost of Revenue | 25.05% | 22.13% | 29.08% | 50.58% | 55.74% |
| Gross Profit | 34.47% | 51.18% | 83.22% | 62.07% | 69.61% |
| SG&A Expenses | 45.89% | 45.69% | 51.59% | 60.76% | 62.49% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 40.22% | 33.59% | 43.04% | 44.11% | 60.02% |
| Operating Income | -56.13% | -28.71% | -30.20% | -23.68% | -55.26% |
| Income Before Tax | -71.39% | -38.73% | 23.59% | 25.64% | -45.94% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -71.39% | -38.73% | 23.59% | 25.64% | -45.94% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -71.39% | -38.73% | 23.59% | 25.64% | -45.94% |
| EBIT | -56.13% | -28.71% | -30.20% | -23.68% | -55.26% |
| EBITDA | -54.38% | -27.37% | -29.16% | -21.72% | -56.50% |
| EPS Basic | -60.69% | -35.13% | 47.19% | 88.78% | 77.73% |
| Normalized Basic EPS | -60.69% | -35.14% | 47.18% | 88.79% | 77.73% |
| EPS Diluted | -60.69% | -35.13% | 47.19% | 88.78% | 77.73% |
| Normalized Diluted EPS | -60.69% | -35.14% | 47.18% | 88.79% | 77.73% |
| Average Basic Shares Outstanding | 6.66% | 2.66% | 44.67% | 563.02% | 555.12% |
| Average Diluted Shares Outstanding | 6.66% | 2.66% | 44.67% | 563.02% | 555.12% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |